Verrica Pharmaceuticals Announces Participation in the 42nd Annual Cowen Virtual Healthcare Conference

February 24, 2022 7:32am

WEST CHESTER, PA – February 24, 2022 (GLOBE NEWSWIRE) – Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will participate in a fireside chat at the 42nd Annual Cowen Virtual Healthcare Conference on Wednesday, March 9, 2022, at 11:10 a.m. ET.

Participants may access a live webcast of the event through the following link:

The webcast can also be accessed in the Investors/Presentations & Events section of the Verrica website at The webcast replay will be available shortly after conclusion of the event for 30 days.



Terry Kohler 
Chief Financial Officer

Kevin Gardner
LifeSci Advisors

Chris Calabrese
LifeSci Advisors